Jazz Pharmaceuticals PLC

21 aug. 2026, 20:06 UTC

Jazz Pharmaceuticals PLC shares are higher during Friday's session, reflecting strong upward momentum since Thursday's close, despite a recent pullback from session highs.

20 aug. 2026, 19:56 UTC

Jazz Pharmaceuticals PLC shares are lower amid a broader market decline following disappointing sales growth and guidance from Walmart. They remain below their 20-day moving average.

19 aug. 2026, 22:36 UTC

Jazz Pharmaceuticals PLC shares are lower in after-market hours, continuing a decline from regular trading, despite a broader recovery in equities.

18 aug. 2026, 20:03 UTC

Jazz Pharmaceuticals shares are trading higher, reflecting strength in the pharmaceuticals sector, despite a slight pullback from earlier session gains.

17 aug. 2026, 23:31 UTC

Jazz Pharmaceuticals PLC shares declined during after-market hours, reflecting broader market pressures from rising crude oil prices amid escalating U.S.-Iran tensions.

12 aug. 2026, 19:46 UTC

Jazz Pharmaceuticals shares are higher after Q2 revenue rose 16% to $1.21 billion, exceeding expectations. The company raised its full-year guidance to $4.68 billion.

11 aug. 2026, 22:46 UTC

Jazz Pharmaceuticals PLC shares advanced in after-market trading, diverging from broader market trends that closed lower amid rising crude oil prices.

10 aug. 2026, 19:56 UTC

Jazz Pharmaceuticals PLC to acquire Actio Biosciences for $820 million, enhancing its rare epilepsy portfolio. Shares are higher despite earlier session pullback.

7 aug. 2026, 19:36 UTC

Jazz Pharmaceuticals shares are higher today, reflecting broader market gains amid expectations the Federal Reserve may pause interest rate hikes.

6 aug. 2026, 19:21 UTC

Jazz Pharmaceuticals PLC shares are lower today, despite earlier gains. Mixed economic signals contribute to cautious sentiment ahead of the non-farm payrolls report.

5 aug. 2026, 19:36 UTC

Shares of Jazz Pharmaceuticals PLC are lower today, despite earlier gains. The company raised its full-year revenue guidance, driven by strong performance from Xywav.

4 aug. 2026, 20:04 UTC

Jazz Pharmaceuticals PLC shares rise as analysts upgrade price targets, following strong Q2 results that beat revenue estimates and boosted 2026 sales guidance.

3 aug. 2026, 23:02 UTC

Jazz Pharmaceuticals reported Q2 revenues of $1.208 billion, exceeding expectations. Shares advanced in after-market trading following the raised full-year guidance.

31 iul. 2026, 23:21 UTC

Jazz Pharmaceuticals PLC shares are lower in after-market trading, pulled back from earlier session highs amid broader market declines, particularly in major tech stocks.

30 iul. 2026, 19:59 UTC

Jazz Pharmaceuticals shares are higher, reflecting broader market recovery amid significant gains in the technology sector. The stock is near the upper end of its one-month range.

29 iul. 2026, 18:26 UTC

Jazz Pharmaceuticals PLC is trading higher during Wednesday's session, with fluctuations within a routine range and positioned above its 20-day moving average.

28 iul. 2026, 23:46 UTC

Jazz Pharmaceuticals PLC shares are higher in after-market trading, recovering from an early low and remaining above the 20-day moving average.

27 iul. 2026, 19:37 UTC

Jazz Pharmaceuticals PLC is trading higher, recently reaching a new 52-week high amid increased investor interest and significant average volume exceeding $50 million.

24 iul. 2026, 20:07 UTC

Jazz Pharmaceuticals PLC shares are lower today amid broader market dynamics influenced by recent oil price volatility, despite remaining above its 20-day moving average.

21 iul. 2026, 19:02 UTC

Jazz Pharmaceuticals PLC is trading higher today, despite no specific news. Positive sentiment in the semiconductor sector may be contributing to overall investor optimism.

20 iul. 2026, 23:36 UTC

Jazz Pharmaceuticals PLC will report second-quarter results on August 3, contributing to positive investor sentiment as shares trade higher after market hours.